Search results
AstraZeneca aims to deliver $80 billion in total revenue by 2030
WSAU Wausau· 14 hours ago(Reuters) -AstraZeneca said on Tuesday it expects to deliver $80 billion in total revenue by 2030,...
AstraZeneca to build $1.5 bln cancer drug facility in Singapore
Medical Xpress· 1 day agoBritish pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant...
From In-House at AstraZeneca to an E-discovery Startup: New Fileread GC Discusses Major Career Move...
Law.com· 1 day agoThe fast evolution of artificial intelligence is spurring a new generation of legal tech...
Stocks making the biggest moves midday: Peloton, Lam Research, Lowe's, AstraZeneca and more
CNBC· 3 hours agoCheck out the companies making the biggest moves midday: Peloton — The stock plunged 14% following...
European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target By Investing.com
Investing.com· 13 hours agoEuropean stock markets slipped lower Tuesday, as the positive momentum at the start of the week...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks· 2 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 12 hours agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
Reuters· 1 day ago, opens new tab plans to build a $1.5 billion manufacturing facility in Singapore to produce a...
Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
Yahoo Finance UK· 12 hours ago“We delivered consistent, profitable growth yet again in Q3 and look forward to executing against...
European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
Investing.com· 15 hours agoEuropean stocks fall in Fed rate concerns; AstraZeneca lifts revenue target